AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionContravisory Investment Management, Inc.
Latest Disclosed Ownership2,994 shares
Latest Disclosed Value $ 651,165
Contravisory Investment Management, Inc. reports 15.80% decrease in ownership of ABBV / AbbVie Inc.

On April 20, 2026 - Contravisory Investment Management, Inc. filed a 13F-HR form disclosing ownership of 2,994 shares of AbbVie Inc. (MX:ABBV) valued at $651,165 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 3,556 shares of AbbVie Inc.. This represents a change in shares of -15.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ABBVIE COM 00287Y109 2,994 -562 -15.80 651 -19.83 0.1334
2026-01-12 2025-12-31 13F ABBVIE COM 00287Y109 3,556 -313 -8.09 813 -9.27 0.1610
2025-10-09 2025-09-30 13F ABBVIE COM 00287Y109 3,869 -1,201 -23.69 896 -4.89 0.1735
2025-07-10 2025-06-30 13F ABBVIE COM 00287Y109 5,070 160 3.26 941 -8.46 0.1851
2025-04-10 2025-03-31 13F ABBVIE COM 00287Y109 4,910 4,867 11,318.60 1,029 14,585.71 0.2167
2025-01-14 2024-12-31 13F ABBVIE COM 00287Y109 43 43 8 0.0016
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 0 -2,576 -100.00 0 -100.00
2023-07-12 2023-06-30 13F ABBVIE COM 00287Y109 2,576 -664 -20.49 347 -32.75 0.0917
2023-04-12 2023-03-31 13F ABBVIE COM 00287Y109 3,240 27 0.84 516 -0.58 0.1457
2023-01-13 2022-12-31 13F ABBVIE COM 00287Y109 3,213 338 11.76 519 34.46 0.1440
2022-10-12 2022-09-30 13F ABBVIE COM 00287Y109 2,875 114 4.13 386 -8.75 0.1288
2022-07-13 2022-06-30 13F ABBVIE COM 00287Y109 2,761 2,111 324.77 423 302.86 0.1372
2022-04-08 2022-03-31 13F ABBVIE COM 00287Y109 650 0 0.00 105 19.32 0.0298
2022-01-12 2021-12-31 13F ABBVIE COM 00287Y109 650 0 0.00 88 25.71 0.0238
2021-10-12 2021-09-30 13F ABBVIE COM 00287Y109 650 0 0.00 70 -4.11 0.0213
2021-07-14 2021-06-30 13F ABBVIE COM 00287Y109 650 0 0.00 73 4.29 0.0215
2021-04-14 2021-03-31 13F ABBVIE COM 00287Y109 650 0 0.00 70 0.00 0.0219
2021-01-13 2020-12-31 13F ABBVIE COM 00287Y109 650 -66,492 -99.03 70 -98.81 0.0217
2020-10-08 2020-09-30 13F ABBVIE COM 00287Y109 67,142 -753 -1.11 5,881 -9.83 2.0038
2020-07-09 2020-06-30 13F ABBVIE COM 00287Y109 67,895 67,245 10,345.38 6,522 12,944.00 2.3972
2020-04-09 2020-03-31 13F ABBVIE COM 00287Y109 650 0 0.00 50 -13.79 0.0222
2020-01-09 2019-12-31 13F ABBVIE COM 00287Y109 650 0 0.00 58 18.37 0.0212
2019-10-07 2019-09-30 13F ABBVIE COM 00287Y109 650 0 0.00 49 4.26 0.0186
2019-07-09 2019-06-30 13F ABBVIE COM 00287Y109 650 0 0.00 47 -9.62 0.0182
2019-04-08 2019-03-31 13F ABBVIE COM 00287Y109 650 0 0.00 52 -13.33 0.0202
2019-01-14 2018-12-31 13F ABBVIE COM 00287Y109 650 0 0.00 60 -1.64 0.0259
2018-10-11 2018-09-30 13F ABBVIE COM 00287Y109 650 -91 -12.28 61 -11.59 0.0219
2018-07-11 2018-06-30 13F ABBVIE COM 00287Y109 741 0 0.00 69 -1.43 0.0252
2018-04-09 2018-03-31 13F ABBVIE COM 00287Y109 741 84 12.79 70 9.38 0.0258
2018-01-18 2017-12-31 13F ABBVIE COM 00287Y109 657 7 1.08 64 10.34 0.0232
2017-10-12 2017-09-30 13F ABBVIE COM 00287Y109 650 650 58 0.0207
2016-04-11 2016-03-31 13F AbbVie com 00287Y109 0 0 0 0.0000
2016-01-12 2015-12-31 13F AbbVie com 00287Y109 0 -3,514 -100.00 0 -100.00
2015-10-15 2015-09-30 13F AbbVie com 00287Y109 3,514 -411 -10.47 191 -27.65 0.0449
2015-07-09 2015-06-30 13F AbbVie com 00287Y109 3,925 0 0.00 264 14.78 0.0574
2015-04-14 2015-03-31 13F AbbVie com 00287Y109 3,925 -400 -9.25 230 -18.73 0.0462
2015-01-12 2014-12-31 13F AbbVie com 00287Y109 4,325 -1,309 -23.23 283 -12.92 0.0572
2014-10-10 2014-09-30 13F AbbVie com 00287Y109 5,634 5,634 -95.92 325 -94.31 0.0678
2013-10-11 2013-09-30 13F AbbVie Inc. com 00287Y109 0 -138,187 -100.00 0 -100.00
2013-07-15 2013-06-30 13F AbbVie Inc. com 00287Y109 138,187 138,187 5,713 1.2701
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.